CORE LABORATORIES N.V.  CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY For the Years Ended December 31, 2013, 2012 and 2011 Common Shares Additional  Paid-In  Capital Retained  Earnings Accumulated  Other  Comprehensive  Income (Loss) Treasury Stock Non-  Controlling Interest Total Equity (In thousands,  except share data) Number of  Shares Par Value Number of Shares Amount BALANCE, December 31, 2010  49,739,912 $ 1,283 $ 114 $ 536,991 $ (6,207)  4,218,726 $ (242,690) $ 2,849 $ 292,340 Stock options exercised, net of capital taxes — — (1,672) — — (42,400) 1,969 — 297 Stock-based compensation, net of awards issued — — 9,588 (1,992) —  (177,271) 9,569 — 17,165 Tax benefit of stock-based awards issued — — 2,559 — — — — — 2,559 Repurchases of common shares — — — — — 669,649 (61,825) — (61,825) Dividends paid — — — (46,027) — — — — (46,027) Cancellation of treasury shares  (702,106) (21) — (40,894) —  (702,106) 40,915 — — Equity component of short-term debt — — 8,864 — — — — — 8,864 Exchange of senior exchangeable notes — — (13,603) (90,192) (1,851,869) 101,473 — (2,322) Settlement of Warrants — — (3,724)  (258,910) —  (706,395) 43,183 — (219,451) Non-controlling interest contributions — — — — — — — 1,194 1,194 Non-controlling interest dividend — — — — — — — (251) (251) Other comprehensive income — — — — 4,468 — — — 4,468 Net income — — — 184,684 — — — (40) 184,644 BALANCE, December 31, 2011  49,037,806 $ 1,262 $ 2,126 $ 283,660 $ (1,739)  1,408,334 $(107,406) $ 3,752 $ 181,655 T he accompanying notes are an integr al part of these Consolidated Financial Statements . 37